Patients with diabetes can receive implant-based treatments with immediate loading safely, providing they present moderate HbA1c values.
No takes yet. Share an insight, caveat, or question.
Aguilar‐Salvatierra et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: